Nutanix executing well but 10-Q filing delay disappointing, says Susquehanna

Susquehanna reviewed the earnings report from Nutanix and said they have been executing well in simplifying product portfolio while hitting profitability and free cash flow targets. Unfortunately, we are disappointed with a delay in filing of 10-Q, lack of financial details and pushout of the Analyst Day. Susquehanna maintains its Positive rating and $34 price target on Nutanix shares.